Skip to Content

KADIAN 20 mg (Morphine sulfate extended-release 20 mg)

Pill imprint KADIAN 20 mg has been identified as Morphine sulfate extended-release 20 mg.

Morphine is used in the treatment of chronic pain; pain and belongs to the drug class narcotic analgesics. Risk cannot be ruled out during pregnancy. Morphine 20 mg is classified as a Schedule 2 controlled substance under the Controlled Substance Act (CSA).

Morphine sulfate extended-release 20 mg KADIAN 20 mg
Morphine sulfate extended-release 20 mg KADIAN 20 mg
Morphine sulfate extended-release
Imprint:
KADIAN 20 mg
Strength:
20 mg
Color:
Yellow
Shape:
Capsule-shape
Availability:
Prescription only
Drug Class:
Narcotic analgesics
Pregnancy Category:
C - Risk cannot be ruled out
CSA Schedule:
2 - High potential for abuse
Manufacturer:
Actavis

View Details Print Imprint Search

Disclaimer: Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Copyright 2016 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.

Hide